Girinimbine Inhibits the Proliferation of Human Ovarian Cancer Cells In Vitro via the Phosphatidylinositol-3-Kinase (PI3K)/Akt and the Mammalian Target of Rapamycin (mTOR) and Wnt/β-Catenin Signaling Pathways
Type
Retraction
Notice date
3/11/2021 0:00
Journal
Medical Science Monitor: International Medical Journal of Experimental and Clinical Research